Verve Therapeutics, Inc.
Verve Therapeutics, Inc. (VERV) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 184 transactions totaling $134.7M, demonstrating a bullish sentiment with $37.1M in net insider flow. The most recent transaction on Jul 25, 2025 involved a transaction of 348,828 shares valued at $0.
VERV Insider Activity Summary
Who Is Buying VERV Stock?
No significant insider buying has been recorded for VERV in the recent period.
Who Is Selling VERV Stock?
No significant insider selling has been recorded for VERV in the recent period.
Is Verve Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VERV is bullish with an Insider Alignment Score of 64/100 and a net flow of $37.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VERV Frequently Asked Questions
Understanding VERV Insider Activity
Insider trading at Verve Therapeutics, Inc. (VERV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading VERV stock, having executed 184 transactions in the past 90 days. The most active insider is Krishna Yeshwant (Executive), who has made 28 transactions totaling $25.4M.
Related Tools
Track Verve Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VERV file new Form 4 transactions